Literature DB >> 18222346

Racial and genetic factors in IgA nephropathy.

Stephen I-Hong Hsu1.   

Abstract

Racial and ethnic variations in the incidence of IgA nephropathy (IgAN) could imply both genetic and environmental influences that exist in a complex and poorly understood interplay to modify the expression of the IgAN clinical phenotype. Progress in identifying genetic factors that influence either susceptibility to IgAN or its progression has been slow. Recent progress using family based approaches (genome-wide scan for linkage and family based genetic association studies) to study the genetic basis for susceptibility to familial and sporadic IgAN strongly point to clinical and genetic heterogeneity in the entity we presently call IgAN. The inconsistent findings reported from case-control genetic association studies may be explained by new understanding of the haplotype block structure of the human genome. Rapid improvements in available and developing technologies in the postgenomic era are needed and are expected to accelerate progress in understanding genetic factors underlying IgAN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222346     DOI: 10.1016/j.semnephrol.2007.10.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  7 in total

1.  HLA has strongest association with IgA nephropathy in genome-wide analysis.

Authors:  John Feehally; Martin Farrall; Anne Boland; Daniel P Gale; Ivo Gut; Simon Heath; Ashish Kumar; John F Peden; Patrick H Maxwell; David L Morris; Sandosh Padmanabhan; Timothy J Vyse; Anna Zawadzka; Andrew J Rees; Mark Lathrop; Peter J Ratcliffe
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

2.  A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy.

Authors:  Xue-Qing Yu; Ming Li; Hong Zhang; Hui-Qi Low; Xin Wei; Jin-Quan Wang; Liang-Dan Sun; Kar-Seng Sim; Yi Li; Jia-Nee Foo; Wei Wang; Zhi-Jian Li; Xian-Yong Yin; Xue-Qing Tang; Li Fan; Jian Chen; Rong-Shan Li; Jian-Xin Wan; Zhang-Suo Liu; Tan-Qi Lou; Li Zhu; Xiao-Jun Huang; Xue-Jun Zhang; Zhi-Hong Liu; Jian-Jun Liu
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 3.  Is IgA nephropathy the same disease in different parts of the world?

Authors:  Hong Zhang; Jonathan Barratt
Journal:  Semin Immunopathol       Date:  2021-08-20       Impact factor: 9.623

4.  The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients.

Authors:  Soumita Bagchi; Ashish Datt Upadhyay; Adarsh Barwad; Geetika Singh; Arunkumar Subbiah; Raj Kanwar Yadav; Sandeep Mahajan; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Kidney Int Rep       Date:  2022-03-24

5.  Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients.

Authors:  Fabio Sallustio; Sharon N Cox; Grazia Serino; Claudia Curci; Francesco Pesce; Giuseppe De Palma; Aikaterini Papagianni; Dimitrios Kirmizis; Mario Falchi; Francesco P Schena
Journal:  Eur J Hum Genet       Date:  2014-10-08       Impact factor: 4.246

6.  Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.

Authors:  S N Cox; F Pesce; J S El-Sayed Moustafa; F Sallustio; G Serino; C Kkoufou; A Giampetruzzi; N Ancona; M Falchi; F P Schena
Journal:  J Intern Med       Date:  2016-10-11       Impact factor: 8.989

7.  Genetic polymorphisms in HLA-DP and STAT4 are associated with IgA nephropathy in a Southwest Chinese population.

Authors:  Bin Yang; Junlong Zhang; Xinle Liu; Zhuochun Huang; Zhenzhen Su; Yun Liao; Lanlan Wang
Journal:  Oncotarget       Date:  2018-01-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.